This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked PENK Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PENK WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~30.8 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +2 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Cleaved | |
| Caveat | Proteolytic processing | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A07495-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A07495-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PENK’s full-length precursor is predicted at 30.8 kDa; cleavage and secretion may affect the blot, but no migration position is demonstrated.
| Band near 30.8 kDa | Consistent with the predicted full-length precursor; identity needs confirmation |
| Band below 30.8 kDa | Could reflect signal-peptide or propeptide cleavage |
| Several smaller bands | Could reflect processing at paired basic residues |
| Little or no band in whole-cell lysate | PENK localizes to secretory vesicles and is secreted |
| Predicted full-length mass | Provides a 30.8 kDa reference for the precursor, not a measured migration position |
| Signal peptide at residues 1–24 | Its cleavage can yield a smaller product than the full-length precursor |
| Propeptide at residues 196–207 | Its cleavage can yield a smaller processed species |
| Cleavage at paired basic residues | Processing can produce smaller fragments of unspecified masses |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PENK is present in secretory vesicles and is secreted | Check a secretory-vesicle-enriched fraction or conditioned medium |
| Band lower than expected | Signal-peptide or propeptide cleavage may reduce size | Compare precursor-enriched and secreted samples with antibodies to mapped regions |
| Multiple bands | The precursor and processed products may coexist | Compare sample fractions and confirm bands with antibodies to distinct PENK regions |
| Weak or no signal | Processing may remove the region recognized by the antibody | Check antibody epitope coverage and probe a precursor-enriched fraction |
| Fragments below expected size | Cleavage at paired basic residues can generate smaller products | Confirm fragment identity with antibodies to mapped precursor regions |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | medullary cells | High | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Medium | Protein (IHC) | HPA → |
| Testis | spermatogonia cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Appendix | endocrine cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PENK, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A07495-1 is a polyclonal anti-PENK antibody listed for Western blot, with a WB image and reported human, mouse, and rat reactivity. The supplied listing gives only a brief image cue, limiting interpretation of the blot evidence.
Which to pick: A07495-1 is the only listed PENK antibody. It has a WB image and reported reactivity for human, mouse, and rat; review the full blot details for your sample and conditions.